January 15, 2026
Q-RETIX AI Announces Series A Funding Round
Company secures significant investment to expand AI-powered pharmaceutical research platform.
Stay updated with the latest announcements, product launches, and company milestones from Q-RETIX AI.
Company secures significant investment to expand AI-powered pharmaceutical research platform.
Q-RETIX AI's latest model demonstrates 40% improvement in compound screening accuracy.
Strategic collaboration to accelerate clinical trial analysis and regulatory compliance.
For media inquiries, interview requests, or additional information about Q-RETIX AI.
Contact Press Team